Ribavirin remains key to achieving SVR with current antiviral strategies for chronic HCV. The mechanism of action of ribavirin in CHC includes effects on the virus and/or the host, including the ...

Ribavirin, the nucleoside analog 1-β-D-ribofuranosyl-1,2,4-triazole-3-carboxamide, is a broad spectrum direct antiviral agent. This drug was discovered more than 40 years ago and is efficient both in ...

Ribavirin (1-β-D-ribofuranosyl-1,2,4-triazole-3-carboxamide) is a purine analogue and a commonly used antiviral agent against both RNA and DNA viruses. With up to five suggested mechanisms of action, ...

The interferon-free regimen of ABT-450 with ritonavir (ABT-450/r), ombitasvir, and dasabuvir with or without ribavirin has shown efficacy in inducing a sustained virologic response in a phase 2 study ...

In patients with chronic infection with hepatitis C virus (HCV) genotype 1, treatment with peginterferon alfa and ribavirin for 48 weeks results in rates of sustained virologic response of 40 to 50%.

Ribavirin 200mg, 400mg, 500mg, 600mg. Ribavirin increases the mutation frequency in the genomes of several RNA viruses and ribavirin triphosphate inhibits HCV polymerase in a biochemical reaction.

With Gift Aid, your generous donation of £10 would be worth £12.50 at no extra cost to you. Yes, I want to Gift Aid any donations made to NAM now, in the future and in the past four years I am a UK ...

Review the side-effects of Ribavirin as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...

The prognosis for patients with respiratory syncytial virus (RSV) or parainfluenza virus type 3 (PIV3) respiratory tract infection post allogeneic haematopoietic progenitor cell transplant (HPCT) is ...

ICN Pharmaceuticals Inc. of Costa Mesa on Monday agreed to pay $1 million and accepted an unusual federal review of its drug-related news releases to settle a lawsuit by the Securities and Exchange ...

J Gastroenterol Hepatol. 2008;23(6):844-855. Recent studies have tested whether treatment of CHC patients with ribavirin alone increases virus mutation rates. In a randomized, placebo-controlled trial ...